AC IMMUNE SA SF-02 (IMR) — Capital Reinvestment Ratio
AC IMMUNE SA SF-02 (IMR) has a Capital Reinvestment Ratio of 0.02x as of December 2024, meaning it reinvests 0% of its operating cash flow (€5.93 Million) in capital expenditures (€90.00K). See IMR equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
AC IMMUNE SA SF-02 Capital Reinvestment Ratio (2024–2024)
This chart tracks AC IMMUNE SA SF-02's Capital Reinvestment Ratio across 1 annual periods. Check IMR total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for AC IMMUNE SA SF-02 (2024–2024)
Year-by-year Capital Reinvestment Ratio for AC IMMUNE SA SF-02 from 2024 to 2024. For live market cap and broader valuation context, see market value of AC IMMUNE SA SF-02.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.01x | €65.84 Million | €576.00K | — |